Tokyo, Japan

Motoi Nakahara

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Mochida Pharmaceutical Co., Ltd.. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motoi Nakahara. Retrieved from https://idiyas.com/inventor/motoi-nakahara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Motoi Nakahara

Introduction

Motoi Nakahara is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Nakahara continues to push the boundaries of medical science.

Latest Patents

Nakahara's latest patents include a novel alginate liquid preparation. This invention provides a ready-to-use sterile alginate aqueous solution that boasts storage stability. The preparation consists of a low-endotoxin monovalent metal salt of alginic acid, a selected salt, and water, with specific concentrations and viscosity requirements. His second patent involves indazolyl-oxo-isothiazole compounds, which are designed to activate Nrf2, a crucial factor in cellular defense mechanisms.

Career Highlights

Nakahara is associated with Mochida Pharmaceutical Co., Ltd., where he has been instrumental in developing innovative pharmaceutical solutions. His work has not only advanced the company's research but has also contributed to the broader field of medicine.

Collaborations

Throughout his career, Nakahara has collaborated with notable colleagues such as Fumihiko Saitoh and Tomoyuki Kamino. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Motoi Nakahara's contributions to the pharmaceutical industry through his patents exemplify the spirit of innovation. His work continues to impact the field positively, showcasing the importance of research and development in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…